Acute exacerbation of paraneoplastic neurological syndrome after massive tumor lysis of neuroendocrine carcinoma by chemoradiotherapy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Klimstra DS, Modlin IR, Coppola D et al (2010) The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 39:707–712
Rudnicki SA, Dalmau J (2000) Paraneoplastic syndromes of the spinal cord, nerve, and muscle. Muscle Nerve 23:1800–1818
Paul T, Katiyar BC, Misra S et al (1978) Carcinomatous neuromuscular syndromes. A clinical and quantitative electrophysiological study. Brain 101:53–63
Trojaborg W, Frantzen E, Andersen T (1969) Peripheral neuropathy and myopathy associated with carcinoma of the lung. Brain 92:71–82
Graus F, Delattre JY, Antoine JC et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135–1140
Pelosof LC, Gerber DE (2010) Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc 85:838–854
Strosberg JR, Coppola D, Klimstra DS et al (2010) The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas 39:799–800
Johnson NT, Crawford SW, Sargur M (1987) Acute acquired demyelinating polyneuropathy with respiratory failure following high-dose systemic cytosine arabinoside and marrow transplantation. Bone Marrow Transplant 2:203–207
Moudgil SS, Riggs JE (2000) Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy. Ann Pharmacother 34:1136–1138
Sarmiento MA, Neme D, Fornari MC et al (2000) Guillain-Barre syndrome following 2-chlorodeoxyadenosine treatment for Hairy Cell Leukemia. Leuk Lymphoma 39:657–659